The Burden of Undiagnosed Diabetes Mellitus in Adult African Population: A Systematic Review and Meta-Analysis

Abstract EN

Background.

The prevalence of diabetes is rapidly increasing in Africa.

Type two diabetes may remain undetected for many years, leading to severe complications and healthcare costs.

This underlines the importance of understanding the magnitude of undiagnosed diabetes in different populations of Africa.

This study is intended to summarize and pool the results of community-based studies to provide a continental level estimate of the undiagnosed diabetes mellitus.

Methods.

We searched MEDLINE/PubMed, HINARI, Cochrane Library, and Google Scholar for community-based studies on diabetes mellitus in Africa.

Descriptive information for the original studies was presented in a table, and the quantitative results were presented in forest plots.

The Cochran’s Q test and I2 test statistic were used to test heterogeneity across studies.

The pooled prevalence of undiagnosed diabetes and subgroup analyses within urban and rural population and diagnostic methods were computed by a random effects model from 2011 to 2017.

Results.

One hundred fifty-seven articles were identified through electronic searching using keywords.

Of these, seventeen studies, with a total population of 20,350, met the inclusion criteria.

A random effects meta-analysis showed that the pooled prevalence of undiagnosed diabetes mellitus in African population was 5.37% (95% CI: 4.57, 6.81).

The pooled prevalence from subgroup analyses indicated that undiagnosed diabetes mellitus in the urban population (8.68%, 95% CI: 5.33, 12.03) is twice higher than that in the rural population (3.93%, 95% CI: 2.91, 4.95).

The prevalence of UDM by OGTT (8.84%, 95% CI: 1.95, 15.73) was higher than that by the FPG diagnostic method (4.54%, 95% CI: 3.59, 5.49).

Conclusion.

This study found high proportions of undiagnosed diabetes mellitus in different communities of the African countries.

Policy makers must consider diagnostic strategies to improve screening for the undiagnosed diabetes mellitus cases for effective care, which can bring about a substantial reduction in diabetes-related complications and mortality.

This review is registered with PROSPERO registration number CRD42018092637.